|
1. Anthony P, Ishak K, Nayak N, Poulsen H, Schener P, Sobin L. The morphology of cirrhosis: definition, nomenclature and classification. Bulletin of World Health Organization;1977. 55.
2. Hyun C, Brann O, Hassanein T. Pegylated Intron A+ribavirin for the treatment of patients with Rebetron refractory chronic hepatitis. C Am J Gastroenterol. 2002;97:116.
3. McGarrity T, Cheb S, Friedrich R. Peg-Intron plus vibavirin in the treatment of chronique C refractory to prior treatment. Am J Gastroenterol. 2002;97:142.
4. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P. A prognostic mode for predicting survival in cirrhosis with ascites. J Hepato. Jan 2001;34(1):46-52.
5. Raymond T, Chung, Daniel K, Podolsky. cirrhosis and it's complications. In: 15, ed. Harrison's principles of internal medecine: McGraw-Hill; 2001.
6. Brunce A. Ascites and spontaneous bacterial peritonitis. In: Feldman, ed. Sleisenger and Fortran's Gastrointertinal and liver disease: W.B. Saunder Campany; 1998:1310-1334.
7. Rungon B, Hoefs J, Morgan T. Ascites fluid analysis in malignancy ralated ascites. Hepatology. 1988;8:1104-1988.
8. Hoefs J. Diagnostic paracentesis: a potent clinical tool. Gastroenterology. 1990;98:230.
9. Hoefs J. Increase in ascites WBC and protein concentration during diuresis in patients with chronic liver disease. Hepatology. 1981;1:249.
10. Hoefs J. Serum protein concentration and portal presure determine the ascites fluid protein concentration in patients with chronic liver disease. J. Lab. Clin. Med. 1983;102:260.
11. Runyon B, Montano A, Akriviadis E. The serum-ascites albumine gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann. Inter. Med. 1992;117:225.
12. Hoefs J. Globulin correction of the albumine gradient; correlation with measured serum to ascites colloid osmotic gradient. Hepatology. 1992;16:1351.
13. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. Aug 2021;74(2):1014-1048.
14. Runyon B. Ascites. In: Yamada T, Alpers D, Owyang C, eds. Textbook of gastroenterology. Philadelphia: J.B. Lippincott; 1995:927-952.
15. Runyon B, Hoefs J. Ascitic fluid analysis before, during, and after spontaneous bacterial peritonitis. Hepatology. 1985;5:257.
16. Runyon B. Cardiac ascites: A characterization. J. Clin. Gastroenterol. 1988;10:410.
17. Akriviadis E, Runyon B. The value of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 1990;98:127.
18. Runyon BA, Van Epps DE. Diuresis of cirrhotic ascites increases its opsonic activity and may help prevent spontaneous bacterial peritonitis. Hepatology. May-Jun 1986;6(3):396-399.
19. Runyon BA, Antillon MR, McHutchison JG. Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis. Journal of hepatology. Mar 1992;14(2-3):249-252.
20. Dolz C, Raurich JM, Ibanez J, Obrador A, Marse P, Gaya J. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology. Mar 1991;100(3):738-744.
21. Powell WJ, Jr., Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med. Mar 1968;44(3):406-420.
22. Veldt BJ, Laine F, Guillygomarc'h A, et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. Journal of hepatology. Jan 2002;36(1):93-98.
23. Reynolds TB, Geller HM, Kuzma OT, Redeker AG. Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med. Oct 13 1960;263:734-739.
24. Arroyo V, Gines P, Rimola A, Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am J Med. Aug 25 1986;81(2B):104-122.
25. De Ledinghen V, Heresbach D, Fourdan O, et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut. Feb 1999;44(2):270-273.
26. de Ledinghen V, Mannant PR, Foucher J, et al. Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study. Journal of hepatology. May 1996;24(5):570-573.
27. Lo GH. Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites. Hepatology. Mar 2011;53(3):1068-1069.
28. Kurt M. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. Apr 2011;53(4):1411-1412.
29. Serste T, Melot C, Francoz C, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. Sep 2010;52(3):1017-1022.
30. BA R. AASLD Practice Guidelines Committee: Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087.
31. Such J. Initial therapy of ascites in patients with cirrhosis. 2013, 2016.
32. Fogel MR, Sawhney VK, Neal EA, Miller RG, Knauer CM, Gregory PB. Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol. 1981;3 Suppl 1:73-80.
33. Perez-Ayuso RM, Arroyo V, Planas R, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology. May 1983;84(5 Pt 1):961-968.
34. Santos J, Planas R, Pardo A, et al. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. Journal of hepatology. Aug 2003;39(2):187-192.
35. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. Oct 15 1998;66(7):956-962.1.
|
